This list is an analysis based on recent market events. It's not an investment recommendation.
About
Coegin Pharma AB, a biotechnology company, develops and commercializes cosmetic technologies for hair and skin in Sweden. Its flagship product is Follicopeptide, a patented, clinically developed peptide technology targeting hair thinning; and NPP-4, a cosmetic peptide product designed to enhance skin tone without UV exposure or chemicals. The company also develops FOL026, a peptide drug candidate for the treatment of myocardial infarction; AVX420, a drug candidate for the treatment of leukemia; and AVX001, a drug candidate for the topical treatment of both actinic keratosis and basal cell carcinoma. Coegin Pharma AB was founded in 2005 and is headquartered in Lund, Sweden.
The current price of COEGIN.ST is SEK2.42 SEK — it has increased by +0% in the past 24 hours. Watch Coegin Pharma stock price performance more closely on the chart.
What is Coegin Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Coegin Pharma stocks are traded under the ticker COEGIN.ST.
How many employees does Coegin Pharma have?▼
As of November 2, 2026, the company has 3 employees.
In which sector is Coegin Pharma located?▼
Coegin Pharma operates in the Other sector.
When did Coegin Pharma complete a stock split?▼
Coegin Pharma has not had any recent stock splits.